Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

323 public trials 61 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Active, not recruiting

Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus

NCT05966480

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Investigator Site #1046 Anniston, Alabama, United States
  • Investigator Site #1104 La Jolla, California, United States
  • Investigator Site #1050 Los Alamitos, California, United States
  • Investigator Site #1168 Mission Hills, California, United States
View all 169 locations
View Trial Details
Active, not recruiting

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

NCT06843239

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +9 more
Locations
  • UCSD Altman Clinical and Translational Research Institute Center for Clinical Research La Jolla, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
  • IRIS Research and Development LLC Plantation, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
View all 60 locations
View Trial Details
Active, not recruiting

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

NCT03162536

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
Locations
  • Mayo Clinic Hospital ( Site 0140) Scottsdale, Arizona, United States
  • UCLA Hematology & Oncology ( Site 0017) Los Angeles, California, United States
  • Colorado Blood Cancer Institute ( Site 0225) Denver, Colorado, United States
  • University of Michigan ( Site 0018) Ann Arbor, Michigan, United States
View Trial Details
Active, not recruiting

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

NCT05186753

Conditions
BMM, Bone Marrow Mastocytosis, Hematologic Diseases, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • One of a Kind Clinical Research Center Scottsdale, Arizona, United States
  • Modena Allergy and Asthma Clinical La Jolla, California, United States
View all 57 locations
View Trial Details

Related conditions